GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Theragen Etex Co Ltd (XKRX:066700) » Definitions » EV-to-EBITDA

Theragen Etex Co (XKRX:066700) EV-to-EBITDA : -3.47 (As of May. 29, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Theragen Etex Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Theragen Etex Co's enterprise value is ₩138,479 Mil. Theragen Etex Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-39,929 Mil. Therefore, Theragen Etex Co's EV-to-EBITDA for today is -3.47.

The historical rank and industry rank for Theragen Etex Co's EV-to-EBITDA or its related term are showing as below:

XKRX:066700' s EV-to-EBITDA Range Over the Past 10 Years
Min: -20070.64   Med: 6.59   Max: 250.6
Current: -3.47

During the past 13 years, the highest EV-to-EBITDA of Theragen Etex Co was 250.60. The lowest was -20070.64. And the median was 6.59.

XKRX:066700's EV-to-EBITDA is ranked worse than
100% of 735 companies
in the Drug Manufacturers industry
Industry Median: 13.89 vs XKRX:066700: -3.47

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-29), Theragen Etex Co's stock price is ₩2980.00. Theragen Etex Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-1410.000. Therefore, Theragen Etex Co's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Theragen Etex Co EV-to-EBITDA Historical Data

The historical data trend for Theragen Etex Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theragen Etex Co EV-to-EBITDA Chart

Theragen Etex Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -235.28 -40.36 8.15 4.23 -4.20

Theragen Etex Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.11 3.82 3.89 -4.20 -3.45

Competitive Comparison of Theragen Etex Co's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Theragen Etex Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Theragen Etex Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Theragen Etex Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Theragen Etex Co's EV-to-EBITDA falls into.


;
;

Theragen Etex Co EV-to-EBITDA Calculation

Theragen Etex Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=138479.278/-39929.338
=-3.47

Theragen Etex Co's current Enterprise Value is ₩138,479 Mil.
Theragen Etex Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-39,929 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Theragen Etex Co  (XKRX:066700) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Theragen Etex Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2980.00/-1410.000
=At Loss

Theragen Etex Co's share price for today is ₩2980.00.
Theragen Etex Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1410.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Theragen Etex Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Theragen Etex Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Theragen Etex Co Business Description

Traded in Other Exchanges
N/A
Address
58, Sandan-ro 68-gil, Danwon-gu, Gyeonggi-do, Ansan-si, KOR
Theragen Etex Co Ltd is a Korea-based company mainly engaged in the manufacturing and selling of finished pharmaceutical products and providing genome sequencing services. It also provides healthcare services. The company's operating segments include its Pharmaceutical business and the Healthcare and Genome Analysis Business. A majority of its revenue is generated from the Pharmaceutical Business which involves the manufacturing and sales of specialized and general medicine along with new drug research and development. The Healthcare and Genome Analysis Business involves DNA sequence analysis, RNA mutation genome analysis and decoding, and the distribution of non-prescription drugs for healthcare purposes. Geographically, the company derives its key revenue from the domestic market.

Theragen Etex Co Headlines

No Headlines